Clinical Trials Directory

Trials / Completed

CompletedNCT00295087

X-Chromosome Inactivation Status and Premature Ovarian Failure

Status
Completed
Phase
Study type
Observational
Enrollment
13 (actual)
Sponsor
University of Pittsburgh · Academic / Other
Sex
Female
Age
20 Years – 40 Years
Healthy volunteers
Accepted

Summary

Women who are affected with premature ovarian failure will exhibit skewed X-chromosome inactivation patterns compared to women with normal menstrual function (as defined by being pregnant), indicating a possible X-chromosome defect.

Detailed description

Premature ovarian failure (POF) affects approximately 1% of women. For most women a cause is not found, but structural abnormalities of the X-chromosome commonly lead to POF, suggesting genes on the X-chromosome are necessary for normal ovarian function. It is known that certain gene mutations on the X-chromosome can lead to changes in the normal random pattern of X-chromosome inactivation in females. We propose to study X-inactivation patterns in a cohort of women with idiopathic POF, and compare their pattern to a mean age-matched cohort of women with normal menstrual function. We hypothesize that some women with POF will show skewed X-inactivation, suggesting a mutation on the X-chromosome as the etiology of their POF.

Conditions

Timeline

Start date
2005-11-01
Primary completion
2009-10-01
Completion
2009-10-01
First posted
2006-02-22
Last updated
2014-12-08

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT00295087. Inclusion in this directory is not an endorsement.

X-Chromosome Inactivation Status and Premature Ovarian Failure (NCT00295087) · Clinical Trials Directory